Alert: Pharma IPR 2014 Conference In Mumbai, 26-28 February 10/02/2014 by Intellectual Property Watch Leave a Comment Dear Subscribers, CPhI’s 3rd Annual Pharma IPR 2014 conference to take place from 26-28 February, 2014 in Mumbai, India will have techno-legal experts from over 10+ regions speaking on the recent case studies on global Pharma and Biopharma patent laws. Among them, Jeffery Alan Hovden, Partner, Robins, Kaplan, Miller & Ciresi LLP from US will be speaking on critical developments in US pharma patent law in the year 2013 which have affected pharma and biopharma industry. He will also share best strategies on how Indian generic-drug and biologics enterprises need to go forward with their US-related projects. Some of the critical concerns he is planning to address include: Which pharmaceutical and diagnostic compounds and processes can even obtain a US patent? Whether the new, cheap and fast patent-challenge procedures are right for Indian companies in the life-sciences area? How to avoid paying the attorney fees for the other side in US litigation and indeed, how an Indian company might turn the tables and have the other side pay the company’s attorney fees? You can view his insights on “US Patent Law in 2013: Winds of Change” by clicking here. To optimise interactions with the audience, he and other global techno-legal experts would also be available in query handling sessions as well as one-on-one meetings, to discuss your concerns related to the US patent system. Click here to go through the detailed programme agenda. You can read more about the conference speakers here. To be a part of this exclusive event, please contact the organisers at +91 (22) 6172 7001 / conferences-india@ubm.com, or register online and take advantage of the special offers for you as you are our subscribers. P.S. You may find one of his earlier presentations on “From Small to Big: Some useful points in the coming shift from customary drugs to biologics” interesting – View the presentation here
WIPO Genetic Resources Text Compiles Differences, Heads To General Assembly 10/02/2014 by Catherine Saez, Intellectual Property Watch 3 Comments Despite spending a week in mostly closed, informal discussions, the World Intellectual Property Organization committee working on the protection of genetic resources, got little closer to breaching the opposing viewpoints. Members managed to produce a draft text – with signs of steps toward a middle ground – that they say can serve as a basis for further discussion on the development of an international instrument preventing wrongful patents.
Small-Scale Farmers’ Innovation Overlooked In WIPO Negotiations, Panellists Say 07/02/2014 by Maëli Astruc for Intellectual Property Watch 1 Comment A side event hosted by the Quaker United Nations Office (QUNO) this week called on negotiators at the World Intellectual Property Organization to include innovation by small-scale farmers and asked for complementarity of several international instruments dealing with this issue.
EPO Appeals Board Upholds Ruling Limiting Stem Cell Patentability 07/02/2014 by Intellectual Property Watch 1 Comment A European Patent Office (EPO) Boards of Appeal this week handed down a verdict in the area of stem cell patenting that could provide further guidance on what is patentable under the European Patent Convention (EPC) when it comes to biotechnology.
New CBD Access And Benefit Sharing Clearing-House Website Presented At WIPO 07/02/2014 by Julia Fraser for Intellectual Property Watch Leave a Comment A new website of the UN Convention on Biological Diversity will allow tracking of the use of genetic resources in order to ensure access and benefit-sharing of those resources.
Developing Countries Urged To Beat Biopiracy With Patent Examination, Regulatory Frameworks 07/02/2014 by Catherine Saez, Intellectual Property Watch 1 Comment While World Intellectual Property Organization members seek ways to address the issue of biopiracy, speakers at a side event to this week’s negotiations said the phenomenon is widespread. According to them, very few patent applicants source the origin of the resources they have used and on which they seek claims. Some measures can be taken […]
Study Maps Global Distribution Of Genetic Resources In Patented Claims 06/02/2014 by Julia Fraser for Intellectual Property Watch Leave a Comment A study of patent activity in the United Kingdom shows widespread global distribution of genetic resources used by UK innovators. The implications of international rules on access and benefit sharing will need to be communicated to these groups, who will among other things have to start assessing their supply chains to ensure full compliance throughout, according to the study author.
Indigenous Panel At WIPO Asks For International Instrument Compliant With Recognised Rights 06/02/2014 by Maëli Astruc for Intellectual Property Watch Leave a Comment A panel addressing negotiators this week at the World Intellectual Property Organization asserted the property rights of Indigenous Peoples and Local Communities over traditional knowledge and genetic resources and called on delegates to draft an international instrument compliant with their internationally recognised rights.
New WIPO Text On Genetic Resources Misappropriation; Disclosure Still Uncertain 06/02/2014 by Catherine Saez, Intellectual Property Watch 4 Comments World Intellectual Property Organization member countries are working to get past their differences this week toward agreement on a way to protect genetic resources from biopiracy. A new document shows focus on misappropriation as a policy objective, and that a bridge still needs to be found on the issue of mandatory disclosure of origin in patent applications.
“No Patents On Seeds” Serves EPO Patent Objection And Free Pepper Soup 03/02/2014 by Intellectual Property Watch 2 Comments 32 farmer, breeder and environmental organisations from 26 countries gathered by the “no-patents-on-seeds” alliance today filed an opposition against a patent on an insect-resistant sweet pepper at the European Patent Office in Munich.